Ami Fazlin Syed Mohamed

Ami Fazlin Syed Mohamed

Auto-generated profile, based on publicly available information

Ami Fazlin Syed Mohamed

Herbal Medicine Research Center, Institute for Medical Research, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NNNor Azrina Norahmad
Nor Azrina Norahmad
MRMohd Ridzuan Mohd Abd Razak
Mohd Ridzuan Mohd Abd Razak
NMNorazlan Mohmad Misnan
Norazlan Mohmad Misnan
NJNur Hana Md Jelas
Nur Hana Md Jelas
USUmi Rubiah Sastu
Umi Rubiah Sastu
AMAmi Fazlin Syed Mohamed
Ami Fazlin Syed Mohamed
Carica papaya leaves have been used for traditional treatment of dengue fever and have been reported to exhibit an immunomodulatory activity by affecting the level of cytokine production in vitro and in vivo. Due to the lack of adequate in vivo evidence in dengue disease model, the present study was initiated to screen and identify the cytokines affected by freeze-dried C. papaya leaf juice (FCPLJ) treatment in AG129 mice infected with DEN-2 dengue virus. The AG129 mice were fed orally with FCPLJ for 3 consecutive days after 24 h of dengue virus inoculation. Plasma cytokines were screened by using ProcartaPlex immunoassay. The gene expression in the liver was analyzed by using RT2 Profiler PCR Array. The results showed that FCPLJ treatment has increased the plasma CCL2/MCP-1 level during peak of viremia. Gene expression study has identified 8 inflammatory cytokine genes which were downregulated in the liver of infected AG129 mice treated with FCPLJ. The downregulated inflammatory cytokine genes were CCL6/MRP-1, CCL8/MCP-2, CCL12/MCP-5, CCL17/TARC, IL1R1, IL1RN/IL1Ra, NAMPT/PBEF1 and PF4/CXCL4. The findings indicated the possible immunomodulatory role of FCPLJ during dengue virus infection in AG129 mice.

11 July 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NANorzahirah Ahmad
Norzahirah Ahmad
DSDodheri Syed Samiulla
Dodheri Syed Samiulla
BTBP Teh
BP Teh
MZMurizal Zainol
Murizal Zainol
NZNor Azlina Zolkifli
Nor Azlina Zolkifli
AMAmi Fazlin Syed Mohamed
Ami Fazlin Syed Mohamed
Eurycoma longifolia is one of the commonly consumed herbal preparations and its major chemical compound, eurycomanone, has been described to have antimalarial, antipyretic, aphrodisiac, and cytotoxic activities. Today, the consumption of E. longifolia is popular through the incorporation of its extract in food items, most frequently in drinks such as tea and coffee. In the current study, the characterisation of the physicochemical and pharmacokinetic (PK) attributes of eurycomanone were conducted via a series of in vitro and in vivo studies in rats and mice. The solubility and chemical stability of eurycomanone under the conditions of the gastrointestinal tract environment were determined. The permeability of eurycomanone was investigated by determining its distribution coefficient in aqueous and organic environments and its permeability using the parallel artificial membrane permeability assay system and Caco-2 cultured cells. Eurycomanone’s stability in plasma and its protein-binding ability were measured by using an equilibrium dialysis method. Its stability in liver microsomes across species (mice, rat, dog, monkey, and human) and rat liver hepatocytes was also investigated. Along with the PK evaluations of eurycomanone in mice and rats, the PK parameters for the Malaysian Standard (MS: 2409:201) standardised water extract of E. longifolia were also evaluated in rats. Both rodent models showed that eurycomanone in both the compound form and extract form had a half-life of 0.30 h. The differences in the bioavailability of eurycomanone in the compound form between the rats (11.8%) and mice (54.9%) suggests that the PK parameters cannot be directly extrapolated to humans. The results also suggest that eurycomanone is not readily absorbed across biological membranes. However, once absorbed, the compound is not easily metabolised (is stable), hence retaining its bioactive properties, which may be responsible for the various reported biological activities.

5 December 2018 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MRMohd Ridzuan Mohd Abd Razak
Mohd Ridzuan Mohd Abd Razak
NMNorazlan Mohmad Misnan
Norazlan Mohmad Misnan
NJNur Hana Md Jelas
Nur Hana Md Jelas
NNNor Azrina Norahmad
Nor Azrina Norahmad
AMAmirrudin Muhammad
Amirrudin Muhammad
AMAmi Fazlin Syed Mohamed
Ami Fazlin Syed Mohamed
Carica papaya leaf juice (CPLJ) was well known for its thrombocytosis activity in rodents and dengue patients. However, the effect of CPLJ treatment on other parameters that could contribute to dengue pathogenesis such as nonstructural protein 1 (NS1) production and viremia level have never been highlighted in any clinical and in vivo studies. The aim of this study is to investigate the effect of freeze-dried CPLJ treatment on NS1 and viremia levels of dengue fever mouse model. The dengue infection in mouse model was established by inoculation of non-mouse adapted New Guinea C strain dengue virus (DEN-2) in AG129 mice. The freeze-dried CPLJ compounds were identified by Ultra-High Performance Liquid Chromatography High Resolution Accurate Mass Spectrometry analysis. The infected AG129 mice were orally treated with 500 mg/kg/day and 1000 mg/kg/day of freeze-dried CPLJ, starting on day 1 post infection for 3 consecutive days. The blood samples were collected from submandibular vein for plasma NS1 assay and quantitation of viral RNA level by quantitative reverse transcription PCR. The AG129 mice infected with dengue virus showed marked increase in the production of plasma NS1, which was detectable on day 1 post infection, peaked on day 3 post-infection and started to decline from day 5 post infection. The infection also caused splenomegaly. Twenty-four compounds were identified in the freeze-dried CPLJ. Oral treatment with 500 mg/kg/day and 1000 mg/kg/day of freeze-dried CPLJ did not affect the plasma NS1 and dengue viral RNA levels. However, the morbidity level of infected AG129 mice were slightly decreased when treated with freeze-dried CPLJ. Oral treatment of 500 mg/kg/day and 1000 mg/kg/day of freeze-dried CPLJ at the onset of viremia did not affect the plasma NS1 and viral RNA levels in AG129 mice infected with non-mouse adapted New Guinea C strain dengue virus.

3 April 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MRMohd Ridzuan Mohd Abd Razak
Mohd Ridzuan Mohd Abd Razak
NNNor Azrina Norahmad
Nor Azrina Norahmad
NJNur Hana Md Jelas
Nur Hana Md Jelas
BJBazilah Jusoh
Bazilah Jusoh
AMAmirrudin Muhammad
Amirrudin Muhammad
AMAmi Fazlin Syed Mohamed
Ami Fazlin Syed Mohamed
The purpose of this study was to profile and identify the endothelial cell biology related genes that are affected by dengue virus infection in the liver tissue of AG129 mice, with and without Carica papaya leaf juice treatment. The dengue fever mouse model was established by intraperitoneal inoculation of dengue virus, New Guinea C strain at 2 × 106 PFU. Daily oral administration of 1000 mg/kg freeze-dried C. papaya leaf juice (FCPLJ) was done starting from day 1 to day 3 post infection. The RNA was extracted from liver tissues harvested on day 4 post infection. The expression levels of 84 genes related to mouse endothelial cell biology were determined by qRT-PCR technique. Dengue virus infection upregulated 15 genes and downregulated two genes in the liver of AG129 mice. The FCPLJ treatment upregulated monocyte chemoattractant protein 1 and downregulated intercellular adhesion molecule 1, integrin beta 3 and fibronectin 1 genes during dengue virus infection. The data showed the potential effect of FCPLJ treatment on the expression profile of endothelial cell biology related genes in the liver of dengue virus infected-AG129 mice. Further proteomic studies are needed to determine the functional roles of the genes affected by FCPLJ treatment.